Literature DB >> 34714551

T1ρ imaging as a non-invasive assessment of collagen remodelling and organization in human skeletal muscle after ligamentous injury.

Brian Noehren1,2,3, Peter A Hardy4,5, Anders Andersen5,6, Camille R Brightwell3,7, Jean L Fry3,7, Moriel H Vandsburger8, Katherine L Thompson9, Christopher S Fry3,7.   

Abstract

Dysregulation and fibrosis of the extracellular matrix (ECM) in skeletal muscle is a consequence of injury. Current ECM assessment necessitates muscle biopsies to evaluate alterations to the muscle ECM, which is often not practical in humans. The goal of this study was to evaluate the potential of a magnetic resonance imaging sequence that quantifies T1ρ relaxation time to predict ECM collagen composition and organization. T1ρ imaging was performed and muscle biopsies obtained from the involved and non-involved vastus lateralis muscle on 27 subjects who had an anterior cruciate ligament (ACL) tear. T1ρ times were quantified via monoexponential decay curve fitted to a series of T1ρ-weighted images. Several ECM indices, including collagen content and organization, were obtained using immunohistochemistry and histochemistry in addition to hydroxyproline. Model selection with multiple linear regression was used to evaluate the relationships between T1ρ times and ECM composition. Additionally, the ACL-deficient and healthy limb were compared to determine sensitivity of T1ρ to detect early adaptations in the muscle ECM following injury. We show that T1ρ relaxation time was strongly associated with collagen unfolding (t = 4.093, P = 0.0007) in the ACL-deficient limb, and collagen 1 abundance in the healthy limb (t = 2.75, P = 0.014). In addition, we show that T1ρ relaxation time is significantly longer in the injured limb, coinciding with significant differences in several indices of collagen content and remodelling in the ACL-deficient limb. These results support the use of T1ρ to evaluate ECM composition in skeletal muscle in a non-invasive manner. KEY POINTS: Dysregulation and fibrotic transformation of the skeletal muscle extracellular matrix (ECM) is a common pathology associated with injury and ageing. Studies of the muscle ECM in humans have necessitated the use of biopsies, which are impractical in many settings. Non-invasive MRI T1ρ relaxation time was validated to predict ECM collagen composition and organization with aligned T1ρ imaging and biopsies of the vastus lateralis in the healthy limb and anterior cruciate ligament (ACL)-deficient limb of 27 subjects. T1ρ relaxation time was strongly associated with collagen abundance and unfolding in the ACL-deficient limb, and T1ρ relaxation time was strongly associated with total collagen abundance in the healthy limb. T1ρ relaxation time was significantly longer in the ACL-deficient limb, coinciding with significant increases in several indices of muscle collagen content and remodelling supporting the use of T1ρ to non-invasively evaluate ECM composition and pathology in skeletal muscle.
© 2021 The Authors. The Journal of Physiology © 2021 The Physiological Society.

Entities:  

Keywords:  T1rho; extracellular matrix; magnetic resonance imaging; muscle fibrosis

Mesh:

Substances:

Year:  2021        PMID: 34714551      PMCID: PMC8764566          DOI: 10.1113/JP281964

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  44 in total

Review 1.  Transcapillary exchange: role and importance of the interstitial fluid pressure and the extracellular matrix.

Authors:  Rolf K Reed; Kristofer Rubin
Journal:  Cardiovasc Res       Date:  2010-05-13       Impact factor: 10.787

Review 2.  Structure and function of the skeletal muscle extracellular matrix.

Authors:  Allison R Gillies; Richard L Lieber
Journal:  Muscle Nerve       Date:  2011-09       Impact factor: 3.217

3.  Evaluation of T1ρ as a potential MR biomarker for liver cirrhosis: comparison of healthy control subjects and patients with liver cirrhosis.

Authors:  Isabel Rauscher; Matthias Eiber; Carl Ganter; Petros Martirosian; Wajima Safi; Andreas Umgelter; Ernst J Rummeny; Konstantin Holzapfel
Journal:  Eur J Radiol       Date:  2014-03-03       Impact factor: 3.528

4.  ACL injury reduces satellite cell abundance and promotes fibrogenic cell expansion within skeletal muscle.

Authors:  Christopher S Fry; Darren L Johnson; Mary Lloyd Ireland; Brian Noehren
Journal:  J Orthop Res       Date:  2017-01-15       Impact factor: 3.494

5.  Wheat germ agglutinin staining as a suitable method for detection and quantification of fibrosis in cardiac tissue after myocardial infarction.

Authors:  B Emde; A Heinen; A Gödecke; K Bottermann
Journal:  Eur J Histochem       Date:  2014-12-17       Impact factor: 3.188

Review 6.  Cellular mechanisms of tissue fibrosis. 4. Structural and functional consequences of skeletal muscle fibrosis.

Authors:  Richard L Lieber; Samuel R Ward
Journal:  Am J Physiol Cell Physiol       Date:  2013-06-12       Impact factor: 4.249

7.  Aberrant repair and fibrosis development in skeletal muscle.

Authors:  Christopher J Mann; Eusebio Perdiguero; Antonio L Serrano; Yacine Kharraz; Susana Aguilar; Patrizia Pessina; Pura Muñoz-Cánoves
Journal:  Skelet Muscle       Date:  2011-05-04       Impact factor: 4.912

8.  In Situ Imaging of Tissue Remodeling with Collagen Hybridizing Peptides.

Authors:  Jeongmin Hwang; Yufeng Huang; Timothy J Burwell; Norman C Peterson; Jane Connor; Stephen J Weiss; S Michael Yu; Yang Li
Journal:  ACS Nano       Date:  2017-09-18       Impact factor: 15.881

Review 9.  Role of the Extracellular Matrix in Loss of Muscle Force With Age and Unloading Using Magnetic Resonance Imaging, Biochemical Analysis, and Computational Models.

Authors:  Usha Sinha; Vadim Malis; Jiun-Shyan Chen; Robert Csapo; Ryuta Kinugasa; Marco Vincenzo Narici; Shantanu Sinha
Journal:  Front Physiol       Date:  2020-06-18       Impact factor: 4.566

10.  Glycosaminoglycans and Contrast Agents: The Role of Hyaluronic Acid as MRI Contrast Enhancer.

Authors:  Alfonso Maria Ponsiglione; Maria Russo; Enza Torino
Journal:  Biomolecules       Date:  2020-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.